Co-Authors
This is a "connection" page, showing publications co-authored by Markus Maeurer and Jun-Liang Fu.
Connection Strength
0.170
-
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021 02 10; 6(1):58.
Score: 0.058
-
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial. Signal Transduct Target Ther. 2020 08 27; 5(1):172.
Score: 0.056
-
Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020 09; 21(9):1107-1118.
Score: 0.056